Pfizer Inc. diskutieren
Pfizer Inc.
WKN: 852009 / Symbol: PFE / Name: Pfizer / Aktie / Pharmazeutika / Large Cap /
21,70 €
0,60 %
Pfizer (NYSE:PFE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its price target raised by HSBC Holdings plc from $29.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) was given a new $27.00 price target by Morgan Stanley. They now have a "positive" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its "underperform" rating reaffirmed by Wolfe Research.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) was upgraded by Wall Street Zen from "hold" to "buy".
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its price target lowered by Guggenheim from $36.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer (PFE) had its price target lowered by BMO Capital Markets from $34.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
Neueste Beiträge
Wolfe_Research in Ashland Inc. diskutieren